Originator Organization |
Active Organization |
Inactive Organization- |
Drug Highest PhasePreclinical |
First Approval Date- |
Regulation- |
Molecular FormulaC28H33ClN6O3 |
InChIKeyUQNVJOYCOQUVLD-XMMPIXPASA-N |
CAS Registry667402-44-0 |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Neoplasms | Preclinical | US | 01 May 2010 |